Recorded Chinese product: 科博肽注射液科博肽注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 吉林省辉南辉发制药股份有限公司Chinese legal name: 吉林省辉南辉发制药股份有限公司
主要成分Active Ingredients
- 以眼镜蛇毒中分离提纯的一种低蛋白Yiyan Jingshe Duzhong Fenli Tichun Deyi Zhongdi Danbai
药物知识说明
以眼镜蛇毒中分离提纯的一种低蛋白是一种在国家药监局注册认定的药品。标注生产企业为吉林省辉南辉发制药股份有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为:吉林省辉南辉发制药股份有限公司Chinese legal name: 吉林省辉南辉发制药股份有限公司、吉林省辉南辉发制药股份有限公司Chinese legal name: 吉林省辉南辉发制药股份有限公司、吉林省辉南辉发制药股份有限公司Chinese legal name: 吉林省辉南辉发制药股份有限公司。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 科博肽注射液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 吉林省辉南辉发制药股份有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 吉林省辉南辉发制药股份有限公司Chinese legal name: 吉林省辉南辉发制药股份有限公司, 吉林省辉南辉发制药股份有限公司Chinese legal name: 吉林省辉南辉发制药股份有限公司, 吉林省辉南辉发制药股份有限公司Chinese legal name: 吉林省辉南辉发制药股份有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 科博肽注射液Recorded Chinese product: 科博肽注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml:70μg2 mL:70 μg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 吉林省辉南辉发制药股份有限公司Chinese legal name: 吉林省辉南辉发制药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H22025631
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H22025631
Manufacturer
Chinese legal name: 吉林省辉南辉发制药股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H22025631
生产企业
吉林省辉南辉发制药股份有限公司(国产)
适应症
用于晚期癌症疼痛、慢性关节痛、坐骨神经痛、神经性头痛,三叉神经痛、麻风反应神经痛等慢性疼痛的治疗,尤其是慢性、顽固性、持续性疼痛的治疗。
用法用量
1.第1次肌注0.25ml,半小时后如无不良反应再注剩余的1.75ml,一日2ml,十日为1疗程。|2.隔三日后可进行第2疗程。|3.第2疗程后,必要时可给予维持量。一周2次,一次2ml。一般用1~2疗程。最大剂量为一日6ml。
不良反应
个别病人可出现口干、头晕、一过性血压下降,一般不用特殊处理。
禁忌
过敏体质、青光眼及高热患者禁用。
注意事项
1.治疗量较安全,剂量过大可引起膈肌麻痹而使呼吸抑制。|2.严重肾病,严重高血压、冠心病患者慎用。|3.有个别病人初用本品疼痛加重,但继续用药效果明显
贮藏
密封,置阴凉处。
规格
2ml:70μg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.